Clinilabs Announces New Affiliation With Rutgers University
Clinilabs (“Clinilabs LLC”), a global full‑service CRO specializing in CNS drug and device development, announced a new partnership with Rutgers Health, School of Health Professions, Master of Science, Clinical Research Management program (MS CRM), reflecting the company’s ongoing commitment to advancing scientific education and strengthening the future clinical research workforce. As one of the nation’s leading public research institutions, Rutgers brings exceptional academic and scientific depth to this collaboration.
Routine FDA Inspection Completed Successfully With No Findings for Clinilabs
Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in CNS drug and device development, today announced it has successfully completed an inspection by the U.S. Food and Drug Administration (FDA) with no observations. This outcome underscores Clinilabs continued commitment to the highest standards of regulatory compliance, operational excellence, and patient safety across its clinical research programs.
Clinilabs Establishes EU Headquarters in Basel, Strengthening European Clinical Operations Under New Regional Leadership
Clinilabs, a leading specialty contract research organization (CRO) focused on central nervous system (CNS) drug and device development, today announced the expansion of its European operations, including the establishment of its European Union headquarters at Switzerland Innovation Park Basel Area, and the appointment of Dr. Anne-Marie Nagy as executive vice president and head of Clinilabs Europe.
